P

Inventor

KRUSE THOMAS

DK61 patents
⚠️ This page may combine multiple inventors who share the name “KRUSE THOMAS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

NOVO NORDISK AS

21 patents
US10005827B2Jun 26, 2018

Double-acylated GLP-1 derivatives

NOVO NORDISK AS24 citations94
US11117947B2Sep 14, 2021

Double-acylated GLP-1 derivatives

NOVO NORDISK AS7 citations83
US11034746B2Jun 15, 2021

Double-acylated GLP-1 derivatives

NOVO NORDISK AS6 citations83
US9409966B2Aug 9, 2016

Glucagon-like peptide-1 derivatives and their pharmaceutical use

NOVO NORDISK AS6 citations83
US9067977B2Jun 30, 2015

Peptides derivatized with A-B-C-D- and their therapeutical use

NOVO NORDISK AS18 citations83
US9023789B2May 5, 2015

Amylin analogs and pharmaceutical compositions thereof

NOVO NORDISK AS11 citations82
US8541368B2Sep 24, 2013

Glucagon analogues

NOVO NORDISK AS6 citations82
US9593149B2Mar 14, 2017

Amylin and calcitonin receptor agonist

NOVO NORDISK AS3 citations70
US11186595B2Nov 30, 2021

Glucose-sensitive albumin-binding derivatives

NOVO NORDISK AS3 citations68
US9029325B2May 12, 2015

Amylin analogues and pharmaceutical compositions thereof

NOVO NORDISK AS2 citations62
US9486505B2Nov 8, 2016

Glucagon analogues

NOVO NORDISK AS2 citations61
US9486506B2Nov 8, 2016

Glucagon analogues

NOVO NORDISK AS1 citations61
US8575091B1Nov 5, 2013

Amylin analogues and pharmaceutical compositions thereof

NOVO NORDISK AS4 citations60
US11767332B2Sep 26, 2023

Glucose-sensitive albumin-binding derivatives

NOVO NORDISK AS1 citations58
US12227528B2Feb 18, 2025

Glucose-sensitive albumin-binding derivatives

NOVO NORDISK AS0 citations57
US12116388B2Oct 15, 2024

Amylin receptor agonists

NOVO NORDISK AS0 citations56
US12054528B2Aug 6, 2024

Co-agonists of the GLP-1 and amylin receptors

NOVO NORDISK AS0 citations52
US9751927B2Sep 5, 2017

Stable, protracted GLP-1/glucagon receptor co-agonists for medical use

NOVO NORDISK AS0 citations51
US9474790B2Oct 25, 2016

Stable, protracted GLP-1/glucagon receptor co-agonists for medical use

NOVO NORDISK AS0 citations51
US10174082B2Jan 8, 2019

Amylin and calcitonin receptor agonist

NOVO NORDISK AS0 citations49
US9988430B2Jun 5, 2018

Stable GLP-1 based GLP-1/glucagon receptor co-agonists

NOVO NORDISK AS1 citations49

HOVEROUND CORP

3 patents

SCHAEFFER LAUGE

3 patents

UNIFY GMBH & CO KG

3 patents

KJAER TANJA MARIA ROSENKILDE

3 patents

DOERKEN EWALD AG

2 patents

AIRBUS DEFENCE & SPACE GMBH

2 patents

KOFOED JACOB

1 patent

SPETZLER JANE

1 patent

MADSEN ALICE RAVN

1 patent

DEFENSIN THERAPEUTICS APS

1 patent

SCHÄFFER LAUGE

1 patent

SIEMENS GAMESA RENEWABLE ENERGY AS

1 patent

STREICHERT FELIX

1 patent

NIELSEN ANETTE SAMS

1 patent

LAU JESPER FAERGEMAN

1 patent

SCHIMMLER MARC

1 patent

BOSCH GMBH ROBERT

1 patent

ZIYLO LTD

1 patent

HOEGENHAUG HANS-HENRIK KRISTENSEN

1 patent

Showing the top 50 of 61 patents by PatentIndex Score.